Houston

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Eosinophilic oesophagitis1 trial
• Multiple myeloma1 trial

Phase

• Phase 1/21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Regeneron Pharmaceuticals2 trials

Closed trials

• Completed

  Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)

  NCT04394351· Phase 3· Regeneron Pharmaceuticals· Source

• Completed

  First In Human (FIH) Study of REGN5459 in Adult Patients With Relapsed or Refractory Multiple Myeloma (MM)

  NCT04083534· Phase 1/2· Regeneron Pharmaceuticals· Source